Review
doi: 10.1007/978-1-4615-6165-1_12.
Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors
Affiliations
- PMID: 9367086
- DOI: 10.1007/978-1-4615-6165-1_12
Item in Clipboard
Review
Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors
Cancer Treat Res.
1997.
No abstract available
Similar articles
-
Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2008 May;19 Suppl 2:ii104-5. doi: 10.1093/annonc/mdn117. Ann Oncol. 2008. PMID: 18456741 No abstract available.
-
Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.Surg Pathol Clin. 2020 Sep;13(3):377-397. doi: 10.1016/j.path.2020.04.002. Surg Pathol Clin. 2020. PMID: 32773190 Review.
-
Endocrine tumors of the gastrointestinal tract.Curr Opin Oncol. 1994 Jan;6(1):72-6. doi: 10.1097/00001622-199401000-00010. Curr Opin Oncol. 1994. PMID: 8204694 Review.
-
Gastroenteropancreatic neuroendocrine tumors. Where are we now?Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:1. doi: 10.1007/s10555-011-9296-x. Cancer Metastasis Rev. 2011. PMID: 21365184 No abstract available.
-
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2010 May;21 Suppl 5:v223-7. doi: 10.1093/annonc/mdq192. Ann Oncol. 2010. PMID: 20555086 No abstract available.
Cited by
-
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.Oncologist. 2011;16(6):835-43. doi: 10.1634/theoncologist.2011-0031. Epub 2011 May 31. Oncologist. 2011. PMID: 21632454 Free PMC article. Clinical Trial.
-
Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.Br J Cancer. 2000 Jul;83(2):171-6. doi: 10.1054/bjoc.2000.1234. Br J Cancer. 2000. PMID: 10901366 Free PMC article.